The downregulation of CASP3, GSDMD, and MLKL expression observed after HP treatment suggests that its protective effects on epithelial barrier integrity and anti-inflammatory properties may have broader therapeutic applications beyond constipation. The gene discussed is MLKL; the disease is Constipation.